Floatz logo

INCOBOTULINUMTOXINA

Detrusor Overactivity

University Of Perugiaprotein_peptidePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Detrusor Overactivity cohort.

Asset / SponsorPhaseRating
Nabiximols
Jazz Pharmaceuticals
Phase 3BB

Same molecule, other indications

INCOBOTULINUMTOXINA is also rated in:

stroke disorderDormant
BBB
Indicative ·
78 / 100
View asset →
Muscle SpasticityDormant
BB
Indicative ·
69 / 100
View asset →
Parkinson diseaseDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →